Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
3.120
-0.300 (-8.77%)
At close: Dec 5, 2025, 4:00 PM EST
3.200
+0.080 (2.56%)
After-hours: Dec 5, 2025, 7:56 PM EST
Tempest Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 13.61 | 13.55 | 11.66 | 12.11 | 9.82 | 4.91 | |
| Research & Development | 22.81 | 28.48 | 17.5 | 22.53 | 17.17 | 14.39 | |
| Operating Expenses | 36.42 | 42.03 | 29.16 | 34.64 | 26.99 | 19.3 | |
| Operating Income | -36.42 | -42.03 | -29.16 | -34.64 | -26.99 | -19.3 | |
| Interest Expense | -0.45 | -1.32 | -1.45 | -1.62 | -1.28 | - | |
| Interest & Investment Income | 0.82 | 1.5 | 1.12 | 0.55 | - | 0.09 | |
| Other Non Operating Income (Expenses) | - | - | - | - | -0.03 | - | |
| Pretax Income | -36.05 | -41.84 | -29.49 | -35.71 | -28.3 | -19.21 | |
| Net Income | -36.05 | -41.84 | -29.49 | -35.71 | -28.3 | -19.21 | |
| Net Income to Common | -36.05 | -41.84 | -29.49 | -35.71 | -28.3 | -19.21 | |
| Shares Outstanding (Basic) | 4 | 2 | 1 | 1 | 0 | 0 | |
| Shares Outstanding (Diluted) | 4 | 2 | 1 | 1 | 0 | 0 | |
| Shares Change (YoY) | 114.19% | 80.99% | 33.49% | 204.70% | 709.63% | -44.17% | |
| EPS (Basic) | -9.71 | -19.50 | -24.87 | -40.20 | -97.07 | -533.38 | |
| EPS (Diluted) | -9.71 | -19.50 | -24.87 | -40.20 | -97.07 | -533.38 | |
| Free Cash Flow | -33.4 | -33.46 | -27.53 | -31.63 | -26.09 | -19.07 | |
| Free Cash Flow Per Share | -9.00 | -15.59 | -23.21 | -35.61 | -89.49 | -529.46 | |
| EBITDA | -36.17 | -41.64 | -28.78 | -34 | -26.61 | -18.96 | |
| D&A For EBITDA | 0.25 | 0.39 | 0.38 | 0.64 | 0.37 | 0.34 | |
| EBIT | -36.42 | -42.03 | -29.16 | -34.64 | -26.99 | -19.3 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.